Author

Christopher B. Damoci

Columbia University Irving Medical CenterORCID 0000-0001-8308-354XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:chromatin & epigenetic regulation· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Agnès BassevilleiD· 1 shared Amy W. KuiD· 1 shared Daniel RomoiD· 1 shared Diana V. MoralesiD· 1 shared Haoran XueiD· 1 shared Helen Elaine RemottiiD· 1 shared Kenneth G. HulliD· 1 shared Kenneth P. OliveiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Agnès BassevilleORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyDrug Resistance UpdatesPeer-reviewedOct 5, 2025

Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic adenocarcinoma

Maryam Safari, Luigi Scotto, Agnès Basseville…·Susan Elaine Bates

This paper shows that combining HDAC and eIF4A inhibitors effectively treats pancreatic cancer by inducing epigenetic reprogramming and metabolic stress in preclinical models.

6 citations

mousebulk RNA-seq

𝕏 PostBluesky